ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,741Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 5176

$1.75M Total Retail Price of All Prescriptions

Rank: 75 out of 5176

835 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 835 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 23,105 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 2,160 2,068 1 2
SIMVASTATIN 1,758 1,673 2 1
LOSARTAN POTASSIUM 1,354 1,299 3 14
EVISTA 725 694 4 65
LOVAZA 685 605 5 43
METFORMIN HCL 658 605 6 7
ATENOLOL 647 598 7 12
GLIMEPIRIDE 587 528 8 37
ALENDRONATE SODIUM 571 535 9 18
METOPROLOL SUCCINATE 507 498 10 11
OMEPRAZOLE 462 413 11 3
CLOBETASOL PROPIONATE 426 399 12 130
ATORVASTATIN CALCIUM 426 410 12 9
ZOLPIDEM TARTRATE 360 342 14 17
DIOVAN 334 313 15 19
AZITHROMYCIN 332 310 16 42
TRICOR 329 312 17 148
TAMSULOSIN HCL 316 290 18 20
NEXIUM 300 283 19 16
CRESTOR 295 245 20 15
SINGULAIR 290 277 21 62
EXFORGE 287 250 22 126
FENOFIBRATE 286 246 23 102
PLAVIX 243 223 24 29
CLOPIDOGREL 234 222 25 26
SYNTHROID 232 232 26 33
LIPITOR 223 223 27 51
LOSARTAN-HYDROCHLOROTHIAZIDE 223 210 27 35
ACTONEL 217 217 29 134
BENICAR 195 195 30 100
MELOXICAM 193 187 31 53
ALLOPURINOL 185 172 32 41
BISOPROLOL-HYDROCHLOROTHIAZIDE 183 173 33 164
LEVOTHYROXINE SODIUM 170 153 34 4
NIFEDIPINE ER 167 140 35 48
FLUTICASONE PROPIONATE 164 147 36 38
RANITIDINE HCL 150 137 37 36
METOPROLOL TARTRATE 143 129 38 6
LIDODERM 141 135 39 59
CIPROFLOXACIN HCL 127 119 40 84
ADVAIR DISKUS 126 120 41 32
POTASSIUM CHLORIDE 124 122 42 34
PREDNISONE 119 115 43 52
JANUVIA 115 95 44 25
AMMONIUM LACTATE 114 107 45 91
AZELASTINE HCL 113 108 46 267
DIOVAN HCT 112 90 47 39
GLIPIZIDE XL 111 111 48 83
TRIAMCINOLONE ACETONIDE 107 101 49 125
AMOXICILLIN 102 94 50 163
CARVEDILOL 101 91 51 24
MECLIZINE HCL 101 96 51 81
DONEPEZIL HCL 99 99 53 28
WARFARIN SODIUM 97 97 54 13
POLYETHYLENE GLYCOL 3350 96 96 55 74
DOXAZOSIN MESYLATE 96 96 55 103
NORTRIPTYLINE HCL 96 83 55 311
MONTELUKAST SODIUM 93 85 58 123
GEMFIBROZIL 91 87 59 139
ISOSORBIDE MONONITRATE ER 89 89 60 44
GABAPENTIN 88 88 61 21
ZETIA 88 75 61 68
FELODIPINE ER 87 87 63 128
FUROSEMIDE 87 87 63 8
SYMBICORT 87 86 63 120
PROAIR HFA 87 74 63 60
JANUMET 86 83 67 77
LISINOPRIL 82 68 68 5
AZOR 81 74 69 194
ACETAMINOPHEN-CODEINE 77 76 S3 70 127
PATADAY 74 72 71 220
PROCTOZONE-HC 74 67 71 171
FINASTERIDE 73 73 73 69
CLOTRIMAZOLE-BETAMETHASONE 71 67 74 94
ONGLYZA 69 54 75 153
VIREAD 68 58 76 250
LEVOFLOXACIN 65 62 77 109
BYSTOLIC 65 65 77 96
PATANOL 64 51 79 158
ALCOHOL SWABS 63 54 80 115
HYDROCHLOROTHIAZIDE 59 59 81 10
LOVASTATIN 58 55 82 46
ACTOS 58 45 82 85
IBUPROFEN 57 56 84 72
SERTRALINE HCL 55 49 85 30
VOLTAREN 54 52 86 97
MICARDIS 54 54 86 154
TRILIPIX 53 53 88 187
GLYBURIDE-METFORMIN HCL 51 51 R 89 76
PROPRANOLOL HCL 50 34 90 199
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.